The landscape of cancer genes and mutational processes in breast cancer

Nature

Volumn 486, Issue 7403, 2012, Pages 400-404

  Stephens, Philip J ^a   Tarpey, Patrick S ^a   Davies, Helen ^a   Van Loo, Peter ^a,b   Greenman, Chris ^a,c,d   Wedge, David C ^a   Nik Zainal, Serena ^a   Martin, Sancha ^a   Varela, Ignacio ^a   Bignell, Graham R ^a   Yates, Lucy R ^a,e,f   Papaemmanuil, Elli ^a   Beare, David ^a   Butler, Adam ^a   Cheverton, Angela ^a   Gamble, John ^a   Hinton, Jonathan ^a   Jia, Mingming ^a   Jayakumar, Alagu ^a   Jones, David ^a   Latimer, Calli ^a   Lau, King Wai ^a   McLaren, Stuart ^a   McBride, David J ^a   Menzies, Andrew ^a   Mudie, Laura ^a   Raine, Keiran ^a   Rad, Roland ^a   Chapman, Michael Spencer ^a   Teague, Jon ^a   Easton, Douglas ^g   Langerød, Anita ^h   Karesen, Rolf ^h,aa   Schlichting, Ellen ^h   Naume, Bjorn ^h,aa   Sauer, Torill ^h,aa   Ottestad, Lars ^h   Lee, Ming Ta Michael ⁱ   Shen, Chen Yang ⁱ   Tee, Benita Tan Kiat ^j   Huimin, Bernice Wong ^k   Broeks, Annegien ^l   Vargas, Ana Cristina ^m   Turashvili, Gulisa ^n,o   Martens, John ^p   Fatima, Aquila ^q   Miron, Penelope ^q   Chin, Suet Feung ^r   Thomas, Gilles ^s   Boyault, Sandrine ^s   Mariani, Odette ^t   Lakhani, Sunil R ^m,u,v   Van De Vijver, Marc ^w   Van't Veer, Laura ^l   Foekens, John ^p   Desmedt, Christine ^x   Sotiriou, Christos ^x   Tutt, Andrew ^e   Caldas, Carlos ^r,y   Reis Filho, Jorge S ^z   Aparicio, Samuel A J R ^n,o   Salomon, Anne Vincent ^t   Børresen Dale, Anne Lise ^h,aa   Richardson, Andrea L ^q,ab   Campbell, Peter J ^a,ac,ad   Futreal, P Andrew ^a   Stratton, Michael R ^a   more..

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d EARLHAM INSTITUTE   (United Kingdom)

^e GUY S HOSPITAL   (United Kingdom)

^f GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h OSLO UNIVERSITY HOSPITAL   (Norway)

ⁱ INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^j SINGAPORE GENERAL HOSPITAL   (Singapore)

^k DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^l NETHERLANDS CANCER INSTITUTE   (Netherlands)

^m UNIVERSITY OF QUEENSLAND   (Australia)

ⁿ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^o BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^p ERASMUS MEDICAL CENTER   (Netherlands)

^q DANA FARBER CANCER INSTITUTE   (United States)

^r UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^s UNIVERSITÉ LYON 1   (France)

^t INSTITUT CURIE   (France)

^u UNIVERSITY OF QUEENSLAND   (Australia)

^v ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^w ACADEMIC MEDICAL CENTER   (Netherlands)

^x JULES BORDET INSTITUTE   (Belgium)

^y CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^z INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^aa UNIVERSITY OF OSLO   (Norway)

^ab BRIGHAM AND WOMEN S HOSPITAL   (United States)

^ac ADDENBROOKE S HOSPITAL   (United Kingdom)

^ad UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROTEIN KINASE B BETA;

CANCER; GENETIC ANALYSIS; GENOME; GENOMICS; MUTATION;

ARID1B GENE; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER GENETICS; CANCER GRADING; CONTROLLED STUDY; COPY NUMBER VARIATION; CORRELATION ANALYSIS; EXON; GENE MUTATION; GENETIC VARIABILITY; GENOME; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAP3K1 GENE; MAP3K13 GENE; NCOR1 GENE; PRIORITY JOURNAL; SMARCD1 GENE; SOMATIC MUTATION; TBX3 GENE; TUMOR GENE;

AGE FACTORS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; CYTOSINE; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MUTAGENESIS; MUTATION; NEOPLASM GRADING; ONCOGENES; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION;

EID: 84861576201     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11017     Document Type: Article

References (38)

1. Stratton, M. R., Campbell, P. J. & Futreal, P. A. The cancer genome. Nature 458, 719-724 (2009).
2. Greenman, C., Wooster, R., Futreal, P. A., Stratton, M. R. & Easton, D. F. Statistical analysis of pathogenicity of somatic mutations in cancer. Genetics 173, 2187-2198 (2006). (Pubitemid 44285695)
3. Varela, I. et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469, 539-542 (2011).
4. Keshet, Y.& Seger, R. TheMAP kinase signaling cascades: a systemof hundreds of components regulates a diverse array ofphysiological functions.Methods Mol. Biol. 661, 3-38 (2010).
5. Su, G. H. et al. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. Cancer Res. 58, 2339-2342 (1998). (Pubitemid 28252690)
6. Carpten, J. D. et al. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 448, 439-444 (2007). (Pubitemid 47123510)
7. Park, H. S. et al. Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation. J. Biol. Chem. 277, 2573-2578 (2002).
8. Carnero, A., Blanco-Aparicio, C., Renner, O., Link, W. & Leal, J. F. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr. Cancer Drug Targets 8, 187-198 (2008). (Pubitemid 351688437)
9. Wu, G. S. The functional interactions between the MAPK and p53 signaling pathways. Cancer Biol. Ther. 3, 146-151 (2004).
10. Horlein, A. J. et al. Ligand-independent repressionby the thyroidhormonereceptor mediated by a nuclear receptor co-repressor. Nature 377, 397-404 (1995).
11. Merrell, K. W. et al. Differential recruitment of nuclear receptor coregulators in ligand-dependent transcriptional repression by estrogen receptor-alpha. Oncogene 30, 1608-1614 (2010).
12. Jones, S. et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 330, 228-231 (2010).
13. Reisman, D., Glaros, S. & Thompson, E. A. The SWI/SNF complex and cancer. Oncogene 28, 1653-1668 (2009).
14. Wiegand, K. C. et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N. Engl. J. Med. 363, 1532-1543 (2010).
15. Spirin, K. S. et al. p27/Kip1 mutation found in breast cancer. Cancer Res. 56, 2400-2404 (1996). (Pubitemid 26154089)
16. Tigli, H., Buyru, N. & Dalay, N. Molecular analysis of the p27/kip1 gene in breast cancer. Mol. Diagn. 9, 17-21 (2005). (Pubitemid 43066365)
17. Chu, I. M., Hengst, L. & Slingerland, J. M. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nature Rev. Cancer 8, 253-267 (2008). (Pubitemid 351430863)
18. Han, J. et al. Tbx3improves the germ-line competency of induced pluripotent stem cells. Nature 463, 1096-1100 (2010).
19. Howard, B. & Ashworth, A. Signalling pathways implicated in early mammary gland morphogenesis and breast cancer. PLoS Genet. 2, e112 (2006).
20. Bamshad, M. et al. Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome. Nature Genet. 16, 311-315 (1997). (Pubitemid 27280219)
21. Fillmore, C. M. et al. Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proc. Natl Acad. Sci. USA 107, 21737-21742 (2010).
22. Ghoussaini, M. et al. Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nature Genet. 44, 312-318 (2012).
23. Varghese, J. S. & Easton, D. F. Genome-wide association studies in common cancers-what have we learnt? Curr. Opin. Genet. Dev. 20, 201-209 (2010).
24. Miller, D. On the nature of susceptibility to cancer. Cancer 46, 1307-1318 (1980).
25. Schinzel, A. C. & Hahn, W. C. Oncogenic transformation and experimental models of human cancer. Front. Biosci. 13, 71-84 (2008). (Pubitemid 351594764)
26. Shuck, S. C., Short, E. A. & Turchi, J. J. Eukaryotic nucleotide excision repair: from understanding mechanisms to influencing biology. Cell Res. 18, 64-72 (2008).
27. Fousteri, M.&Mullenders, L. H. Transcription-coupled nucleotide excisionrepair in mammalian cells: molecular mechanisms and biological effects. Cell Res. 18, 73-84 (2008).
28. Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589-595 (2010).
29. Ye, K., Schulz, M. H., Long, Q., Apweiler, R. & Ning, Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25, 2865-2871 (2009).
30. Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proc. Natl Acad. Sci. USA 107, 16910-16915 (2010).
31. Varela, I. et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469, 539-542 (2011).
32. Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589-595 (2010).
33. Ye, K., Schulz, M. H., Long, Q., Apweiler, R. & Ning, Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25, 2865-2871 (2009).
34. Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proc. Natl Acad. Sci. USA 107, 16910-16915 (2010).
35. Beroukhim, R. et al. The landscape of somatic copy-number alteration across human cancers. Nature 463, 899-905 (2010).
36. Futreal, P. A. et al. A census of human cancer genes. Nature Rev. Cancer 4, 177-183 (2004). (Pubitemid 38337497)
37. Greenman, C. et al. Patterns of somatic mutation in human cancer genomes. Nature 446, 153-158 (2007). (Pubitemid 46398669)
38. Nelder, J. A., &. Wedderburn, R. Generalized linear models. J. R. Stat. Soc. A 135, 370-384 (1972).